Hot Life Science Investor Mandate 3: PE Provides Secure Venture Debt Loans to Medtech

~ Next Phase Admin
A private equity group based in Canada has around $500 million in assets, and is currently deploying capital from its fourth fund, which raised nearly $200 million. The firm is seeking greater exposure to the life sciences, and while they do not have a set timeframe to make allocations, the group would invest in a new firm within the next six months if a compelling opportunity were identified.

The PE provides secured venture debt loans ranging from $2-15 million and has the ability to syndicate loans as large as $30 million for public companies. They are most interested in medical technology firms that are developing medical devices. The firm will only consider medtech companies that have products that are currently on the market. The firm will consider both US- and Canadian-based firms. The firm only considers funds that have at least $5 million in revenue, and will consider both private and public firms.

Unknown's avatar

Published by Next Phase Admin

Leave a comment